# Organon & Co. (OGN) — merger/definitive [announced]
Source: SEC API (secapi.ai) · situation sit_1a45b0e30f3648b7f170 · retrieved 2026-08-11T16:15:23.069Z

## Overview
Organon & Co. is a pharmaceutical company engaged in the development and commercialization of pharmaceutical preparations.

Organon & Co. held a special stockholder meeting on July 23, 2026 to vote on a merger with Sun Pharmaceutical Holdings USA, Inc. Under the Agreement and Plan of Merger dated April 26, 2026, Sun Pharma America, Inc. (a wholly owned subsidiary of Sun Pharma USA) will merge with and into Organon, with Organon surviving as a wholly owned subsidiary of Sun Pharma USA. The merger was approved with 192,776,552 votes in favor, 2,573,118 votes against, and 326,189 abstentions, representing 74.51% of the 262,609,433 outstanding shares as of the June 15, 2026 record date.

## Terms
- Counterparty: Sun Pharmaceutical Holdings USA, Inc. · Stake: 100%

## Key dates
- Announced 2026-07-23 · Record 2026-06-15 · Vote 2026-07-23

## Timeline
- 2026-07-23 · 8-K (0001193125-26-314587): 8-K - Organon & Co. — *Organon & Co. is a pharmaceutical company engaged in the development and commercialization of pharmaceutical preparations.* Organon & Co. held a special stockholder meeting on July 23, 2026 to vote on a merger with Sun Pharmaceutical Holdings USA, Inc. Under the Agreement and Plan of Merger dated April 26, 2026, Sun Pharma America, Inc. (a wholly owned subsidiary of Sun Pharma USA) will merge with and into Organon, with Organon surviving as a wholly owned subsidiary of Sun Pharma USA. The merger was approved with 192,776,552 votes in favor, 2,573,118 votes against, and 326,189 abstentions, representing 74.51% of the 262,609,433 outstanding shares as of the June 15, 2026 record date.
  https://www.sec.gov/Archives/edgar/data/1821825/0001193125-26-314587.txt

## Citations
- 0001193125-26-314587 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526314587